Citation tools
"90Y-Ibritumomab Tiuxetan Consolidation After Autologous Stem Cell Transplantation Improves Survival of Patients with Intermediate-/High-risk Diffuse Large B-cell Lymphoma Not Responding Adequately to First-line Treatment." Anticancer Research
34.9
(2014):
5121-5125.
Web. 03 Oct. 2023.